Among main difficulties of targeting solid tumors using CAR T cells is the lack of tumor-specific membrane antigens or antigens that are shared by dispensable cell types such as B cells, which prompt many to use suboptimal targets such as PD-L1. The gene discussed is CD274; the disease is neoplasm.